Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury (Q39642476)

13 September 2017

Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury (English)

1 reference

13 September 2017

T K Ali

1

1 reference

13 September 2017

M M H Al-Gayyar

2

1 reference

13 September 2017

S Matragoon

3

1 reference

13 September 2017

B A Pillai

4

1 reference

13 September 2017

M A Abdelsaid

5

1 reference

13 September 2017

J J Nussbaum

6

1 reference

13 September 2017

A B El-Remessy

7

1 reference

13 September 2017

19 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

54

1 reference

13 September 2017

657-668

1 reference

13 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-010-1935-1

13 September 2017

0 references

cites work

Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

21 January 2018

12 December 2020

Diabetic retinopathy: current management and experimental therapeutic targets.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Serum and tear levels of nerve growth factor in diabetic retinopathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Regulation of cell survival by secreted proneurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Commentary: Regulating proNGF action: multiple targets for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Diverse roles of Rho family GTPases in neuronal development, survival, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Dysfunction of retinal neurons and glia during diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Diabetic retinopathy: more than meets the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Pro-NGF secreted by astrocytes promotes motor neuron cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Simvastatin improves diabetes-induced coronary endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1935-1

Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death

21 January 2018

1 reference

12 December 2020

A central role for inflammation in the pathogenesis of diabetic retinopathy

1 reference

12 December 2020

p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.

1 reference

12 December 2020

Neurotrophins in the developing and regenerating visual system.

1 reference

12 December 2020

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

1 reference

12 December 2020

Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

1 reference

12 December 2020

Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture.

1 reference

12 December 2020

Stimulation of nerve growth factor expression in astrocytes by peroxynitrite.

1 reference

12 December 2020

Establishment and characterization of a retinal Müller cell line.

1 reference

12 December 2020

10.1007/S00125-010-1935-1

Identifiers

DOI

1 reference

13 September 2017

1 reference